Gaining. It is time to admit that conventional wisdom has been wrong every step of the way. In this market, patience is not a virtue discipline cluster of fortune. Buying the most obvious stock, well, that has been a strategy that was easy i struggle about how this is possible i am not used to a mark that reward investors being late to the party. We found out moderna has a vaccine that may work better than pfizer. Thats getting off the table we got uncontrol spread over america. And mayors and governors refused to shutdown the bars and restaurants. Those are the main places we are getting infected no, it is at home, jim this pandemic is steam rolling us the prospect of a vaccine keeps on plotting it and shutting everything down. I am sure you are wondering, given the numbers that we see, how is that possible first every now and then there were moments that well stood on our head. Time like these is not sell. You must be willing to suspend judgment how far stocks can reasonably go. Than
The session. High intraday high russell 2000 continues its high but it, too, has faded during the session. The russell flat, the other indices negative coming up in todays show, well ask allianz chief economic adviser Mohamed El Erian about todays highs plus, the president of shopify about the companys new partnership with alipay mike santoli, tracking the market action. Meg tirrell has more news on pfi zechlt rs vaccine data and phil lebeau, covering the boeing 747 max. Mike, start us off here. Weve been dealing with a couple of issues, the market being a little stretched on the upside after that strong rally month to date. Over bullish sentiment has had a hard time getting traction, but no damage done at this point on the year to date chart were slightly above that september high by half a percent nothing damaging really happening here i wanted to zoom into the last ten days of trading or basically really more like eight days of trading, back to last monday, week ago monday. Pfizer n
More than 30,000 people in the United States took part in modernas phase 3 study. Among them 95 were confirmed to have covid19 two weeks after the vaccine. 90 were observed in the placebo group, and five in the vaccinated group. 11 developed severe cases, all within the placebo group. Based on their interim analysis of the data the firm estimates the vaccine had an estimated 94. 5 efficacy and says there were no significant safety concerns. Moderna is part of the United States operation wp spee ich as to accelerate the e hd of e programays the and dernaaccine wld b eas t administer bauseheaccine cabe stored at standar to a month. Temraturesor up as oppos tthe pfizer vaccin which will require specialized storage to ensure temperates remain between minus 60 and minus 80 degrees celsius. If approved by regulators, moderna expects to have about 20 million doses ready to ship in the u. S. By the end of this year and is on track to manufacture up to 1 billion doses for global use in 2021. An
Trade. Meanwhile joe biden pushes ahead with the set transition and makes plans to fill critical posts donald trump has so far refused to could see the race. Im sure welcome to the program we begin with breaking News Pharmaceuticals giant pfizer house announced that its im the Coronavirus Vaccine developed in partnership with a German Company build tech is 90 percent effective the 2 companies are the 1st to show successful data from a large scale trial of such a vaccine pfizer. Found no serious safety concerns and expect to see calls for emergency use in the United States this month the number of covered 90 infections has now exceeded 50000000 worldwide according to a Johns Hopkins university in the u. S. So lets explore this with to be a support whos an epidemiologist a retired hospital welcome to you how significant do you feel this news is. Well i think this is a significant step and we know that several companies are working on back scenes and so were hoping to hear this news. Soon
Plans to fill critical. To the program we begin with breaking News Pharmaceuticals giant pfizer has announced that its Coronavirus Vaccine developed in partnership with German Company built on tech is 98 percent effective 2 companies are the 1st to show successful data from a trial such a vaccine. Found no serious safety concerns and expect to see. Emergency use in the United States this month. So lets explore this with to be a support an epidemiologist a. Hospital welcome to you how significant do you feel this news is. Well i think this is a significant step and we know that several companies are working on that since and were hoping to hear this news. Soon and so today we heard the news however we have to understand this is an interim analysis so does this not the end of the trial that is currently still ongoing and its a press release so we have not seen the data in detail but we have very. Positive that this data hold true and that a lot of people who are vaccinated are protected